Since the reversion of BRCA germline mutations has been reported to be associated with the acquisition of resistance to chemotherapy in ovarian cancer [25], we also searched for changes in BRCA1/2 mutations and we did not detect any germline mutation reversion. The gene discussed is BRCA1; the disease is ovarian carcinoma.